The FDA has approved testing of a new pro-coagulant, Thrombin-VSI, made by a company called Vascular Solutions:
The clearance will allow Vascular to study the performance of its Thrombin-VSI as a component in its existing hemostatic devices. Those devices, often resembling clamps, are used during surgery to control bleeding.
The Thrombin analog would be incorporated into existing VS devices, such as the D-Stat.
More from Vascular Solutions…